Latest papers

Newly identified CHO ERCC3/XPB mutations and phenotype characterization.

Newly identified CHO ERCC3/XPB mutations and phenotype characterization.

Newly identified CHO ERCC3/XPB mutations and phenotype characterization.

Newly identified CHO ERCC3/XPB mutations and phenotype characterization.

Newly identified CHO ERCC3/XPB mutations and phenotype characterization.

Newly identified CHO ERCC3/XPB mutations and phenotype characterization.

Newly identified CHO ERCC3/XPB mutations and phenotype characterization.

Newly identified CHO ERCC3/XPB mutations and phenotype characterization.

Newly identified CHO ERCC3/XPB mutations and phenotype characterization.

Newly identified CHO ERCC3/XPB mutations and phenotype characterization.

Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors.

Discovery of carmegliptin: a potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab - A report of 29 patients.

Preparation of RGD-modified long circulating liposome loading matrine, and its in vitro anti-cancer effects.

Arylalkylamine-, beta-carboline-, quinolizine- and azecine-derived compounds and their in vitro interaction with the ionotropic 5-HT3 receptor: search for new lead structures.

[Effect of oxymatrine on JAK/STAT iteral in rat lung tissue with sepsis]

[Epileptic seizure-like effect of Sophora alkaloid sophoridine on experimental animals]

Matrine induces cell anergy in human Jurkat T cells through modulation of mitogen-activated protein kinases and nuclear factor of activated T-cells signaling with concomitant up-regulation of anergy-associated genes expression.

Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron.

Antiarrhythmic properties of long-term treatment with matrine in arrhythmic rat induced by coronary ligation.